N1-Methyl-2'-beta-C-methyl adenosine

N1-Methyl-2’-beta-C-methyl adenosine is a purine nucleoside analog with broad-spectrum antitumor properties, showing particular efficacy against indolent lymphoid cancers. Its mechanisms, studied in vitro and in vivo, involve the inhibition of DNA synthesis and the induction of apoptotic cell death.